CIPHER Grant Programme – Annual programme

The CIPHER Grant Programme provides a unique opportunity for early-stage investigators to address research gaps in paediatric and adolescent HIV in resource-limited settings, in order to promote evidence-based HIV policies and programmes in these settings. The grants are for up to US$150,000 for two years and 80% of grants awarded go to applicants from low- and middle-income countries. The Collaborative Initative for Paediatric HIV Education and Research (CIPHER) is an initiative of the International AIDS Society; this programme is made possible through support from CIPHER Founding Sponsor ViiV Healthcare and Janssen.

Read more

CIPHER Growing the Leaders of Tomorrow Fellowship Programme – Biennial programme

The CIPHER Growing the Leaders of Tomorrow Fellowship Programme contributes to strengthened HIV clinical research capacity in high-burden countries in sub-Saharan Africa by providing two-year research fellowships to emerging young leaders in paediatric HIV clinical science. The fellowship provides up to US$70,000 for the fellow to work with an established mentor on a funded research project that addresses a key gap in paediatric and adolescent HIV clinical science. The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) is an initiative of the International AIDS Society; this programme is made possible through support from CIPHER Founding Sponsor ViiV Healthcare.

Read more

IAS/Abivax Research-for-Cure Academy Fellowship Prize – Annual prize

The IAS Research-for-Cure Academy provides training on state-of-the-art HIV cure research to talented investigators and clinical scientists interested in advancing the HIV cure field in resource-constrained settings. This US$2,000 annual prize is presented to one outstanding fellow based on their engagement during the academy, collaborative spirit during the project work and continued engagement in the HIV cure field.

Previous prize winners

See the list of winners from previous years.

IAS 2019
Natalia Laufer, Argentina, for her active engagement and valuable input to the collaborative research projects at the Research-for-Cure Academy. Natalia works as a as a physician, basic/clinical researcher, teacher and as a member of a community outreach programme.

AIDS 2018
Paradise Madlala, South Africa, for his active engagement and valuable input to the collaborative research projects at the Research-for-Cure Academy.

IAS President’s Award – Biennial award

The IAS President’s Award aims to recognize the achievements of an individual who demonstrates a history of leadership and excellence a pioneer or advocate at the forefront of the response to HIV and AIDS. The award highlights an individual’s contribution that results in increased knowledge, skills, creative solutions or evidence-based policies and programmes to enhance the global response to HIV.

The IAS President’s Award is a recognition award with no monetary value. The prize consists of a statue and a certificate setting forth the reasons for the award.

To be eligible for the award, the individual must meet the following criteria:

  • The individual must be nominated by two or more members of the International AIDS Society Governing Council from at least two regions;
  • The nominee demonstrates a long history of leadership and excellence as a pioneer at the forefront of the response to HIV and AIDS;
  • The nominee demonstrates throughout their career that they act as a strong advocate for implementation of effective, evidence-based policies and programmes that enhance the global response to AIDS.

Previous prize winners

See the list of winners from previous years.

AIDS 2016
Dr. Anthony Fauci, USA, for his leadership at the forefront of the HIV response.

AIDS 2014
Dr. Eric Goosby, USA, in recognition of his long-term commitment, leadership and experience working in the HIV filed at local, national and global levels.

AIDS 2012
Dr Michel Kazatchkine, France, for his impact on the epidemic and his contribution to expand access to antiretroviral treatment.

AIDS 2010
Dr Jack Whitescarver, USA, for his outstanding commitment to the global fight against HIV and his pioneering work in the field.

IAS/MSD Prize for Operational and Implementation Research in Differentiated Service Delivery – Annual prize

The International AIDS Society and Merck Sharpe & Dohme (MSD) award a co-partnered prize for the top-scoring abstracts in operational and implementation research in differentiated service delivery. The prize recognizes outstanding research that addresses key knowledge gaps and links new evidence to strategic programme priorities in differentiated service delivery. The prize (US$10,000 per recipient) is awarded to the four highest-scoring abstracts. It is funded by MSD.

Eligible candidates are presenting authors of regular and late-breaker abstracts submitted to AIDS 2020, who meet the following criteria:

  • The abstract has been accepted as an oral presentation, for a poster discussion session or for the poster exhibition.
  • The research demonstrates innovation, originality, rationale and quality.
  • The abstract presents data on differentiated service delivery for HIV.

Abstract submitters do not need to apply for the prize. All abstracts that meet the criteria will be automatically considered.

Previous prize winners

 See the list of winners from previous years.

IAS 2019

Jennifer Zech, United States, “Optimizing treatment models for people living with HIV in urban Zimbabwe: Findings from a mixed methods study”

Vivian Chitiyo, Zimbabwe, “Differentiated antiretroviral therapy delivery: A review of implementation progress and challenges in Zimbabwe”

Didier Kamerhe, Democratic Republic of the Congo, “Improved HIV treatment retention among patients enrolled in a differentiated care model at Kenya General Reference Hospital in Haut Katanga province of the Democratic Republic of the Congo”

Bruce Agins, United States, “Improving rapid ART initiation in Blantyre, Malawi, through implementation of a quality improvement collaborative”

Elizabeth Taylor Human Rights Award – Biennial award

The Elizabeth Taylor Human Rights Award recognizes the efforts of individuals who have achieved major breakthroughs or shown exceptional courage in their efforts to advocate for human rights in the field of HIV. The award is supported by the International AIDS Society and the Foundation for AIDS Research (amfAR) to pay a lasting tribute to Dame Elizabeth Taylor, who has been a highly visible, vocal, and relentless champion of human rights in the HIV field.

From the early days of the AIDS epidemic until her passing in March 2011, Dame Elizabeth Taylor, amfAR’s Founding International Chairman, was one of the strongest advocates for the respect of human rights of all people living with or affected by HIV.

The Elizabeth Taylor Human Rights Award, which is awarded every two years at the International AIDS Society-convened International AIDS Conferences, came into effect in 2012 and was awarded for the first time at the opening ceremony of the XIX International AIDS Conference (AIDS 2012). The Elizabeth Taylor Human Rights Award is a recognition award, with no monetary value. The prize consists of a statue and a certificate setting forth the reasons for the award.

Previous prize winners

See the list of winners from previous years.

AIDS 2018
Allan Achesa Maleche, Kenya, executive director of the Kenya Legal and Ethical Issues Network on HIV and AIDS (KELIN). Maleche and his colleagues have litigated landmark cases protecting the rights of people affected by HIV and tuberculosis.

AIDS 2016
Martha Tholanah, Zimbabwe, in recognition of her outstanding efforts to advocate for Human Rights inthe field of HIV.

AIDS 2014
Paul Semugoma, Uganda, in recognition of his outstanding efforts to advocate for Human Rights in the field of HIV.

AIDS 2012
Arash and Kamiar Alaei, Iran, in recognition of their efforts to advocate for Human Rights in the field of HIV.

IAS/ANRS Dominique Dormont Prize – Annual prize

The US$5,000 IAS/ANRS Dominique Dormont Prize is funded by the Dominique Dormont Association. The prize supports young researchers working on chronic conditions in humans, with a particular focus on the interface between HIV and other chronic diseases. It highlights researchers who demonstrate originality, rationale, quality and a multidisciplinary and integrative approach in the field of HIV and AIDS research.

Eligible candidates are presenting authors of abstracts submitted to AIDS 2020, which meet the following criteria:

  • The abstract has been accepted as an oral presentation.
  • The research demonstrates originality, rationale, quality and multidisciplinary and integrative approach in the field of HIV and AIDS research.
  • The presenting author is under 40 years of age.

Previous prize winners

See the list of winners from previous years.

IAS 2019
Shalena Naidoo, South Africa “Persistence of myeloid cell-associated inflammation in HIV-infected children after 8 years on early initiated therapy – the key role players in HIV persistence?”

AIDS 2018
Stéphane Isnard, Canada “Relevance of Reg3α and I-FABP on microbial translocation, inflammation and reservoir size in people living with HIV”

IAS 2017
Maria Salgado, Spain “Achievement of Full Donor Chimerism with Episodes of Alloreactivity Contributes to Reduce the HIV Reservoir after Allogeneic Stem Cell Transplantation.”

Prize for Excellence in HIV Research Related to Children – Biennial prize

There is an urgent need to advance the scientific understanding of paediatric HIV and the psychosocial impact of the epidemic on children in order to enhance practices of prevention, treatment and care. With the aim of drawing the attention of the scientific community to children living with and affected by HIV and AIDS, the IAS/CCABA Prize for Excellence in HIV Research Related to Children was first awarded at the XVIII International AIDS Conference in Vienna, Austria, in 2010.

The US$2,000 prize is jointly offered by the International AIDS Society and the Coalition for Children Affected by AIDS (CCABA). One prize is awarded to an investigator whose abstract demonstrates excellence in research that is likely to lead to improved services for children affected by HIV and AIDS.

Eligible candidates are presenting authors of abstracts submitted to AIDS 2020, which meet the following criteria:

  • The abstract must have been accepted as an oral presentation, poster discussion or poster exhibition.
  • Research must be related to the needs of children affected by HIV (using the UNICEF definition of a child aged 0-18 years). Research focusing on the integration of care and support is encouraged, especially highlighting the impact of holistic approaches.
  • The research site must include low- or middle-income countries .

Previous prize winners

See the list of winners from previous years.

AIDS 2018
RamadhaniAbdul, Tanzania, “Child labour in Tanzanian small-scale gold mines: high HIV and violence risk”Claire Davies, South Africa, “Cohort study of HIV+ children in Southern Africa returning to care after being lost to follow up: effect of interrupting care on mortality”

AIDS 2016
Makhahliso Jubilee, Lesotho, for the abstract, ‘Index Tracking model as a strategy in finding children and adolescents, and improving effective referrals’ Theresa Betancourt, United States, for the abstract, ‘Family-based promotion of mental health in children affected by HIV: a pilot randomized controlled trial’

AIDS 2014
Louise Kuhn, USA, for the abstract, “HIV antibody detection in children who started antiretroviral treatment in infancy”.

AIDS 2012
Gabriel Anabwani, Botswana, for the abstract, “The psychosocial impact of HIV on the siblings of infected children”.

AIDS 2010
Priscilla Akwara, USA, for her abstract, “Who is the vulnerable child? Using survey data to identify children at risk in the era of HIV and AIDS”.

Women, Girls and HIV Investigator’s Prize – Biennial prize

This US$2,000 prize is funded by the International AIDS Society and UNAIDS, with the support of the International Community of Women with HIV/AIDS. The vulnerability of women and girls to HIV infection and accelerated disease progression is well documented. As HIV incidence continues to increase among women and girls, particularly in resource-limited settings, research on gender-related issues, including community-based interventions and investigations, will provide critical evidence and information on to inform our response.

The Women, Girls and HIV Investigator’s Prize was introduced in 2008 to support young female investigators from resource-limited settings whose abstracts demonstrate excellence in research and/or practices that address women, girls and gender issues related to HIV and AIDS. Since AIDS 2010, partners have agreed to change eligibility to allow any researcher (male or female, regardless of age) to receive the award as long as the criteria are met. The purpose of the Women, Girls and HIV Investigator’s Prize is to encourage research in low- and middle-income countries that can benefit women and girls affected by HIV and AIDS.

Eligible candidates are presenting authors of abstracts submitted to AIDS 2020, which meet the following criteria:

  • The Scientific Programme Committee has accepted the abstract as an oral presentation, for a poster discussion session or for the poster exhibition.
  • The abstract demonstrates excellence in research and/or practice that addresses women, girls and gender issues related to HIV and AIDS.
  • The abstract title contains at least one of the following keywords: “women”, “girls”, “gender”.
  • The presenting author is a national of a low- or middle-income country .
  • The investigation has taken place in a low- or middle-income country .

Previous prize winners

See the list of winners from previous years.

AIDS 2018
Zachary Kwena, Kenya, “Barriers to linkage and retention in HIV care among adolescent girls and young women (AGYW) in communities around Lake Victoria in Western Kenya”

IAS 2017
Brendan Maughan-Brown, South Africa “HIV and HSV-2 risk among young women in age-disparate partnerships: evidence from KwaZulu-Natal, South Africa”

AIDS 2016
Sinaye Ngcapu, South Africa, for the abstract, ‘Effect of injectable hormonal contraceptives on vaginal epithelium thickness and genital HIV target cell density in women recently infected with HIV’.

IAS 2015
Jean Wysler Domercant, Haiti, for the abstract, “Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti”.

AIDS 2014
Xu-Dong Zhang, China, for the abstract “Sexual and reproductive health in adolescent female sex workers: Kunming, China”.

IAS 2013
Definate Nhamo, Zimbabwe, for the abstract “Factors associated with gender-based violence and unintended pregnancy among adolescent women living with HIV in Zimbabwe”.

AIDS 2012
Peter Mudiope, Uganda, for the abstract “Partnership of HIV infected mothers (peers), community lay women/men (Sengas/Kojas) and village health teams (VHTs) with prevention of mother-to-child HIV transmission (PMTCT) programs, increased male partner support for HIV infected women in one rural health centre and three urban hospitals in Uganda, July 2009 – July 2011”.

IAS 2011
Milly Kaggwa Nanyombi, Uganda, for her abstract “Preventing HIV Infection among adolescents by addressing Cross Generational Sex (CGS) in Secondary Schools in Uganda”.

AIDS 2010
Naina Rani Mangalore, India, for her abstract “Mainstreaming the Prevention of Parent to Child Transmission (PPTCT) Program with the National Rural Health Mission (NRHM): Experiences from Southern India”.

IAS 2009
Linnet N. Masese, Kenya, for her abstract “A prospective cohort study of the effect of antiretroviral therapy on sexual risk behaviour in a high-risk cohort of Kenyan women.”

AIDS 2008
Paola E. Pérez Maldonado, Mexico, for her abstract “The Condomovila: taking HIV information and prevention to the most vulnerable Mexican women”.

AIDS 2006
Penelope Campbell from Jamaica, for her abstract “Baseline study informs establishment of a mobile unit providing HIV/AIDS/STI information, skills and services to vulnerable adolescents”.

Prudence Mabele Prize – Biennial prize

The Prudence Mabele Prize is a $25,000 endowment named in honour of the life and work of Prudence Mabele, a trailblazing activist for the rights of women and people living with HIV. In 1992, she became the first black woman to publicly reveal her HIV-positive status in South Africa, and she was a founding member of the Treatment Action Campaign and founder of the Positive Women’s Network.

The International AIDS Society created the prize in 2018 through an endowment from the Ford Foundation and the Open Society Foundations, and in partnership with the Positive Women’s Network of South Africa. The prize carries the largest monetary value awarded at the International AIDS Conference.

The selected honouree will be a woman (cis or trans) whose work and personal commitment best embodies the values, spirit and activism of Prudence Mabele. They will be publicly honoured at a high-level session at the International AIDS Conference.

In 2018, the Prudence Mabele Prize was awarded to Duduzile (Dudu) Dlamini at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam, the Netherlands. Read more about Dudu and her achievements in the media release.

Consideration will be based on the following criteria:

  • Nominations are invited for women (cis and trans) making deep connections between the fight against HIV, feminism and gender and reproductive justice.
  • Potential recipients should match the values that Prudence embodied:
    • Innovativeness: Demonstrate the creativity of the nominee in their work, in line with the innovation Prudence showed throughout her life.
    • Perseverance: Illustrate the tenacity of the nominee in achieving their accomplishments.
    • Social justice: Exemplify how the nominee enhances social justice in both their work and personal life, with an emphasis on gender activism and vulnerable people.
  • We encourage applications from around the world. Strong consideration will be given to applicants from the region where the conference is hosted. To honour and commemorate Prudence’s early activism and the courage she showed as a young women openly speaking about her HIV-positive status, preference will also be given to applications from young people (under the age of 35, according to the definition in the African Youth Charter).

Timeline

  • 17 March: Submissions open
  • 4 May: Submissions close

Previous prize winners

See the list of winners from previous years.

AIDS 2018

Duduzile Dlamini (South Africa), a long-time advocate for the rights and health of sex workers and founder of Mothers for the Future (M4F), a network striving to reverse the factors that make sex workers and their families particularly vulnerable to stigma, discrimination and HIV.

Robert Carr Research Award – Biennial award

The Robert Carr Research Award recognizes a research project conducted by a community-academia partnership that has led to evidence-based programmes and/or influenced policies in the field of HIV to guide a human rights-based response. The Robert Carr Research Award is a joint initiative of the International AIDS Society (IAS), the International Council of AIDS Service Organizations (ICASO), Caribbean Vulnerable Communities (CVC) and the Johns Hopkins Center for Public Health and Human Rights (CPHHR). The award is sponsored by the IAS, ICASO and the Open Society Foundations (OSF).

Dr Robert Carr was the Executive Director of the Caribbean Vulnerable Communities Coalition, the Policy and Advocacy Director of ICASO and a human rights activist who highlighted stigma and discrimination against people living with or affected by HIV and AIDS. His commitment to translating findings from research collaborations between community and academic partners into advocacy efforts, evidence-based programmes and tangible policy is the driving force behind this prize.

To be eligible for the award, the research project must meet the following criteria:

  • The research project has been nominated by an IAS Governing Council member, an ICASO Board of Directors member, an HRW Health and Human Rights Division’s Advisory Committee member or a CPHHR Advisory Board member.
  • The research project has been conducted by a community-academia partnership in which all partners were equally involved in designing the study, collecting and analysing the data and disseminating the results.
  • The research project has led to evidence-based programmes and/or influenced policies in the field of HIV to guide a human rights-based response to HIV.
  • For the 2020 award, preference will be given to projects that address issues of race and/or migration and HIV.

For more information, or to submit a nomination for the Robert Carr Award, please visit ICASO’s website here.

Previous prize winners

See the list of winners from previous years.

AIDS 2018

Cesar Galindo, Guatemala, and Claire Barrington, USA, “Expanding the options: a case study of collective action to create a community-based Pre-Exposure Prophylaxis clinic for MSM in Guatemala City”

AIDS 2016

Keith Hambl, Canada and Sean Rourke, Canada, “Positive Spaces Healthy Places: HIV, Housing and Health Research in Action”

AIDS 2014

Dr. Kay Thi Win, Myanmar, “Sex Work and Violence: Understanding Factors for Safety and Protection”

Dr. Marta Vallejo Mestres, Spain, “Sex Work and Violence: Understanding Factors for Safety and Protection”

ViiV Healthcare Positive Action HIV Challenge

The ViiV Healthcare Positive Action HIV Challenge, in partnership with the International AIDS Society and the International Network of People who Use Drugs, will award funding for game-changing solutions that provide comprehensive, innovative and accessible harm reduction services at the community level for people who inject drugs. Seed awards of £25,000 to pilot a brand-new idea and grand awards of £75,000 to scale up an existing project will be awarded at AIDS 2020.

IAS/ANRS Lange/van Tongeren Prizes for Young Investigators – Annual prizes

The six US$2,000 IAS/ANRS Lange/van Tongeren Prizes for Young Investigators are jointly funded by the International AIDS Society and the France Recherche Nord & Sud Sida-HIV Hépatites (ANRS) to support young researchers who demonstrate innovation, originality, rationale and quality in the field of HIV research. The prizes are granted to the top-scoring abstract in each of the six tracks: Track A (Basic and Translational Research); Track B (Clinical Research); Track C (Epidemiology and Prevention Research); Track D (Social and Behavioural Research); Track E (Implementation Research, Economics, Systems and Synergies with other Health and Development Sectors) and Track F (Political Research, Law, Policy and Human Rights). In 2015, the Young Investigator Prize was permanently renamed in memory of Joep Lange and Jacqueline van Tongeren.

For the International AIDS Conference, in addition to the prize, the Joep Lange Institute will support the six recipients to attend the INTEREST conference (flight, accommodation and registration costs). They will also have the opportunity to participate in a presentation session during the conference.

Eligible candidates are presenting authors of abstracts submitted to AIDS 2020, which meet the following criteria:

  • The Scientific Programme Committee has accepted the abstract as an oral presentation, for a poster discussion session or for the poster exhibition.
  • The research demonstrates innovation, originality, rationale and quality.
  • The presenting author is under 35 years of age.

Abstract submitters do not need to apply for the prize. All abstracts that meet the criteria will be automatically considered.

Previous prize winners

See the list of winners from previous years.

IAS2019

Track A: Basic science
Stéphane Isnard, Canada, “Relevance of Reg3α and I-FABP on microbial translocation, inflammation and reservoir size in people living with HIV”

Track B: Clinical science
Faith Moyo, South Africa, “Characterizing viral load burden among HIV-infected women at time of delivery: Findings from four tertiary obstetric units in Gauteng, South Africa”

Track C: Prevention science
Matthew A. Spinelli, United States, “Homelessness at diagnosis is the strongest predictor of death among persons with HIV in a population-based study of a U.S. city”

Track D: Implementation science
Carrie Lyons, United States, “Utilizing individual level data to characterize the relationship between HIV infection and the legal context of sex work across 10 countries in sub Saharan Africa”

AIDS 2018 

Track A: Basic and translational research
Shaheed Abdulhaqq, United States, for the abstract “RhCMV-induced, SIV-specific MHC-E-restricted T cells recognize SIV through the T cell receptor”

Track B: Clinical research
Jonathan Chang, United States, for the abstract “Persistent immune activation and depression in rural Ugandans initiating antiretroviral therapy”

Track C: Epidemiology and prevention research
Michael Traeger, Australia, for the abstract “Changes, patterns and predictors of sexually transmitted infections in gay and bisexual men using PrEP; interim analysis from the PrEPX demonstration study”

Track D: Social and political research, law, policy and human rights
Kalonde Malama, Zambia, for the abstract “Prevalence and predictors of violence against female sex workers in Zambia”

Track E: Implementation research, economics, systems and synergies with other health and development sectors
Francis Matthew Simmonds, Zimbabwe, for the abstract “Task shifting for point-of-care early infant diagnosis testing: comparison of error rates between nurses and specialized laboratory trained personnel”

IAS 2017 

Track A: Basic Science
Christine Fennessey, United States, for the abstract “Assessing individual viral reactivations of the latent reservoir using a novel barcoded virus”

Track B: Clinical Science
Nithya Srinivas, United States, for the abstract “SHIV infection and drug transporters influence brain tissue concentrations of efavirenz”

Track C: Prevention Science
Kelly Kilburn, United States, for the abstract “The effect of a conditional cash transfer for HIV prevention on the experience of partner violence for young women: evidence from a randomized experiment in South Africa HPTN 068”

Track D: Implementation Science
Margaret Prust, United States, for the abstract “Multi-month refills of antiretroviral drugs for stable patients in Malawi: assessing accuracy in the application of eligibility criteria at the health facility level”

AIDS 2016  

Track A: Basic and Translational Research
Jacques Dutrieux, France, for the abstract ‘PML/TRIM19-dependent inhibition of retroviral reverse-transcription by Daxx’.

Track B: Clinical Research
MunyaradziPasipamire, Swaziland, for the abstract ‘Evaluating the incremental value of using the TB LAM test in intensified case finding for TB in people living with HIV’.

Track C: Epidemiology and Prevention Research
José Luis Gomez, Brazil, for the abstract ‘Trans incarceration experiences, cycle of violence and increased risk of HIV infection: results from Muriel Project, Sao Paulo, Brazil’.

Track D: Social and Political Research, Law, Policy and Human Rights
LeighBukowski, United States, for the abstract ‘Physical assault partially mediates the impact of transgender status on depression and poly-substance use among Black MSM and Black transgender women in the United States: results from POWER’.

Track E: Implementation Research, Economics, Systems and Synergies with other Health and Development Sectors 
Pedro Carneiro, United States, for the abstract ‘Implementing a successful PrEP program: lessons learned from the largest LGBT Community Health Clinic in New York City’.

Special HIV Cure Prize
Tianyu He, United States, for the abstract, ‘T regulatory cell depletion in controller macaques reactivates SIV and boosts CTLs’.

IAS 2015

Track A: Basic Science
Eunok Lee, Australia, for the abstract, “Distinct HIV genetic populations in effector memory T-cells after prolonged therapy”.

Track B: Clinical Science
Kristjana Asbjornsdott, USA, for the abstract, “T-cell activation and treatment outcomes among infants receiving early ART”.

Track C: Prevention Science
Marc Solomon, USA, for the abstract, “The safety of HIV pre-exposure prophylaxis in the presence of hepatitis B infection”.

Track D: Implementation Science
Anu Ramachandran, USA, for the abstract, “Cost effectiveness of implementing CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda”.

Special HIV Cure Prize
Christopher Peterson, USA, for the abstract, “Zinc finger nuclease gene editing for functional cure in a nonhuman primate model of HIV/AIDS”.

AIDS 2014

Track A: Basic and Translational Research
Matthew Woods, Canada, for the abstract Interferon-induced HERC5 protein inhibits HIV-1 replication by two novel mechanisms and is evolving under positive selection”.

Track B: Clinical Research
Sarah E. Rutstein, USA, for the abstract “Identifying persons with acute HIV infection in urban Malawi HIV testing and sexually transmitted infection clinics: an opportunity for HIV transmission prevention”.

Track C: Epidemiology and Prevention Research
Jilian Pintye, USA, for the abstract “Male circumcision and the incidence of syphilis acquisition among male and female partners of HIV-1 serodiscordant heterosexual African couples: a prospective study”.

Track D: Social and Political Research, Law, Policy and Human Rights
Lucie Cluver, South Africa, for the abstract “Threefold increased suicide attempt incidence amongst AIDS-affected and abused adolescents in South Africa: a prospective national study”.

Track E: Implementation Research, Economics, Systems and Synergies with other Health and Development Sectors
Ashley Grosso, USA, for the abstract “Prevention and treatment needs of women who started selling sex as minors”.

Special HIV Cure Prize
Gilles Darcis, Belgium, for the abstract “Synergistic activation of HIV-1 expression by compounds releasing active positive transcription elongation factor b (P-TEFb) and by inducers of the NF-kB signaling pathway”.

IAS 2013

Track A: Basic Sciences 
Kavidha Reddy, South Africa, for the abstract “Association of APOBEC3G genetic variants with HIV-1vif sequence variation and impact on HIV-1”.

Track B: Clinical Sciences 
Michael Schomaker, South Africa, for the abstract “When to start ART in children aged 2-5 years? Causal modeling analysis of IeDEA southern Africa”.

Track C: Prevention Science
Jennifer Smith, United Kingdom, for the abstract “Could misreporting of condom use explain the apparent association between injectable hormonal contraceptives and HIV acquisition risk?”.

Track D: Operation and Implementation Research
Raluca Buzdugan, Romania, for the abstract “Feasibility of population-based cross-sectional surveys for estimating vertical HIV transmission: data from Zimbabwe”.

Special HIV Cure Prize
Lachlan Gray, Australia, for the abstract “HIV-1 entry and trans-infection in astrocytes: implications for cure and eradication”.

AIDS 2012

Track A: Basic Sciences
Rik Schrijvers, Belgium, for the abstract “Dissecting HIV-1 integration site selection using a human LEDGF/p75 knockout cell line”.

Track B: Clinical Sciences 
Vikrant Sahasrabuddhe, USA, for the abstract “HPV genotype attribution of anal neoplasia in HIV-positive MSM: estimating the preventable fraction and disease misclassification”.

Track C: Epidemiology and Prevention Science 
Renee Heffron, USA, for the abstract “Association of injectable contraception and risk of HIV-1 acquisition in women in HIV-1 serodiscordant partnerships: persistence of effect in multiple sensitivity analyses”.

Track D: Social Science, Human Rights and Political Science 
Kathleen Deering, Canada, for the abstract “Mapping spatial barriers and facilitators to HIV testing by work environments among sex workers in Vancouver, Canada”.

Track E: Implementation Science, Health Systems and Economics 
Caitlin A Matson, USA, for the abstract “Integration of infant HIV testing at nine month immunisation visit in South Africa: a proposed model of service delivery”.

Special HIV Cure Prize
Nitasha Kumar, Australia, for the abstract “Myeloid dendritic cells and HIV latency in resting T cells”.

IAS 2011

Track A: Basic Sciences 
Xu Yu, China, for her abstract “Unique mechanisms of CD4 T cell homeostasis in HIV-1 elite controllers”.

Track B: Clinical Sciences 
Musa Ngayo, Kenya, for his abstract “Association of abnormal vaginal flora with male-to-female HIV-1 transmission among HIV-1 discordant couples in sub-Saharan Africa”.

Track C: Prevention Science 
Anadi Sheth, USA, for her abstract “Genital secretions of HIV-1 infected women on effective antiretroviral therapy contain high drug concentrations and low amounts of cell-free virus”.

Track D: Operations and Implementation Research 
Lilanganee Telisinghe, UK, for her abstract “Antiretroviral therapy roll-out in an African prison: It can be done”.

AIDS 2010

Track A: Basic Sciences 

Stephanie Planque, USA, for her abstract “Prototype covalent HIV vaccine for inducing antibodies that neutralize genetically divergent virus strains”.

Track B: Clinical Sciences 

Gabriel Chamie, USA, for his abstract “TB microbiologic and clinical outcomes in a randomized trial of immediate vs. CD4 initiated antiretroviral therapy in HIV-positive adults with high CD4 cell counts”.

Track C: Biomedical Prevention 

Joseph Larmarange, Mali, for his abstract “Mapping HIV prevalence in Africa for a better understanding of epidemics: example from Burkina Faso using 2003 demographic and health survey data”.

Track D: Operations Research 

Michaela Leslie-Rule, USA, for her abstract “The language of love: Tanzanian women define intimacy, sexuality and violence in the 21st century”.

Track E: Economics, Operations Research, Care and Health Systems 

Gesine Meyer-Rath, South Africa, for her abstract “Total cost and potential cost savings of the national antiretroviral treatment (ART) programme in South Africa, 2010 to 2017”.

Track F: Policy, Law, Human Rights and Political Science 

Khalil Elouardighi, France, for his abstract “Biogeneric development: when trade secret law clashes with research ethics”.

IAS 2009

Track A: Basic Sciences 

Renato Aguiar, Brazil, for his abstract “HIV encapsidates viral genomic RNA and APOBEC3G in mRNA processing bodies.”

Track B: Clinical Sciences

Max O’Donnell, USA, for his abstract “High incidence of multidrug resistant and extensively drug resistant tuberculosis among South African health care workers.”

Track C: Biomedical Prevention 

Ashraf Fawzy, USA, for his abstract “Diarrhea morbidity and mortality increases with weaning prior to 6 months among uninfected infants born to HIV-infected mothers in Zambia.”

Track D: Operations Research 

Ingrid Bassett, USA, for her abstract “Who starts ART in Durban, South Africa?…not everyone who should.”

AIDS 2008 ANRS/IAS Prize

María Lorena Cabrera Ruíz, Paraguay, for her abstract “Prevalence of Resistance-Associated-Mutations in HIV-infected Mexican Children after multiple ARV failure”.

David Damba, Uganda, for his abstract “Improving Quality of Life of Persons Living with HIV/AIDS through a Computerized Drug Management System – TASO Mbale Experience”.

Joyce Wamoyi, Kenya, for her abstract “Women’s bodies are shops”- Beliefs about transactional sex and implications for understanding gender power and HIV prevention in Tanzania”.

AIDS 2008 IAS Young Investigator Awards

Track A: Biology and Pathogenesis of HIV 

Birgitt Dau, USA, for her abstract “Connection Domain Mutations Are Common in Treatment-Experienced Patients and Are Associated with Virologic Outcome”.

Track B: Clinical Research, Treatment and Care 

Alastair Teague, United Kingdom, for his abstract “Clinical experience with raltegravir (MK-0518 or Isentress®), with an optimised background regimen in highly treatment-experienced patients”.

Track C: Epidemiology, Prevention and Prevention Research 

Tara Beattie, United Kingdom, for her abstract “Community mobilization – an approach for rapid increases in condom use and reductions in sexually transmitted infections among female sex workers in Mysore, South India”.

Track D: Social, Behavioural and Economic Science 

Kenneth Gimbel-Sherr, USA, for his abstract “Task shifting to mid-level clinical health providers: An evaluation of quality of ART provided by tecnicos de medicina and physicians in Mozambique”.

Track E: Policy 

Richard Pearshouse, Canada, for his abstract “Rape, sexual assault, domestic violence and HIV: promoting women’s rights through legislation”.

IAS 2007 ANRS/IAS Prize

Track A: HIV Basic Science

Dmytro Kovalskyy, Ukraine, for his abstract “Development of small molecule inhibitors of HIV-1 Tat- protein phosphatase-1 interaction as a new anti-HIV-1 retroviral therapeutics”.

Track B: Clinical Research, Treatment and Care 

Apollo Basenero, Uganda, for his abstract “Inadequacy of clinical and immunological criteria in identifying virologic failure of 1st line ART: the Ugandan experience”.

Track C: Biomedical Prevention 

Lu Yin, China, for her abstract “Incidence of HIV and hepatitis C viruses among injection drug users in Southwestern China: a 3-year follow-up study”.

IAS 2007 IAS Young Investigator Awards

Track A: HIV Basic Science 

Miranda Zoe Smith, Australia, for her abstract “Vaccine-induced CD8+ T cells control reversion of SIV Gag immune escape mutants”.

Track B: Clinical Research, Treatment and Care 

Marcello Pinti, Italy, for his abstract “Upregulation of the mitochondrial PRSS15/LON during lipodistrophy: ex vivo and in vitro detection”.

Track C: Biomedical Prevention 

Viviane D. Lima, Canada, for her abstract “The impact of HAART on HIV transmission: the interplay of HIV-1 RNA plasma viral load, adherence and drug resistance over time”.

Track C: Biomedical Prevention

Biswajyoti Borkakoty, India, for his abstract “Co-infection of HIV, HCV, HBV and the associated risk behaviors among injection drug users in two northeastern states of India”.

AIDS 2006 ANRS/IAS Prize

Dorothy Balaba, Uganda, for her abstract “Building referral networks between traditional health practitioners and biomedical health system – a strategy to reach the underserved communities with comprehensive HIV services”.

Le Minh Giang, Vietnam, for his abstract “HIV risks among young male migrants using heroin in Hanoi, Vietnam”.

AIDS 2006 IAS Young Investigator Awards

Track A: Biology and Pathogenesis of HIV 

Linos Vandekerckhove, Belgium, for his abstract “The LEDGF-integrase interaction as a new target for ART”.

Track B: Clinical Research, Treatment and Care 

Assane Diouf, Senegal, for his abstract “Tuberculosis incidence and risk factors among adult patients receiving HAART in Senegal: a 7-year cohort study”.

Track C: Epidemiology, Prevention and Prevention Research 

Sheri Weiser, USA, for her abstract “Food insufficiency predicts high-risk sexual behavior among women but not men in Southern Africa”.

Track D: Social, Behavioural and Economic Science 

Gretchen Domek, USA, for her abstract “The social consequences of antiretrovirals: preparing for the unexpected futures of HIV-positive children in South Africa”.

Track E: Policy 

Savy Bou, Cambodia, for her abstract “Living again: supporting PLHA to lead the response to HIV”.